Health - Latest News Search Engine - Global and Local Breaking News

Health

Life Time Announces Pricing of Secondary Offering of 20,000,000 Shares of Common Stock

CHANHASSEN, Minn., June 5, 2025 /PRNewswire/ -- Life Time Group Holdings, Inc. (NYSE: LTH) ("Life Time" or the "Company") announced today the pricing ...

Life Time Announces Pricing of Secondary Offering of 20,000,000 Shares of Common Stock

DISCO topline results: 64Cu-SARTATE is highly effective in detecting tumours in NET patients compared to SOC imaging. Phase III planning underway.

HIGHLIGHTS Topline data from Clarity's diagnostic Phase II trial, DISCO, confirms that 64Cu-SARTATE is safe and highly effective compared to standard-...

DISCO topline results: 64Cu-SARTATE is highly effective in detecting tumours in NET patients compared to SOC imaging. Phase III planning underway.

AKC Canine Health Foundation Announces $170k Donation from Irish Setter Club of America Foundation

RALEIGH, N.C., June 5, 2025 /PRNewswire/ -- The AKC Canine Health Foundation (CHF), a non-profit organization dedicated to improving the lives of all ...

AKC Canine Health Foundation Announces $170k Donation from Irish Setter Club of America Foundation

New Study Finds Pycnogenol® Alleviates Cellulite in Women

Peer-reviewed, published research reveals new skin health benefits for the super-antioxidant, including significant skin smoothness and cellulite redu...

New Study Finds Pycnogenol® Alleviates Cellulite in Women

OpenEvidence and the JAMA Network sign strategic content agreement

OpenEvidence users benefit from multimedia and full-text content sourced from JAMA, JAMA Network Open, and JAMA specialty journals CAMBRIDGE, Mass., J...

OpenEvidence and the JAMA Network sign strategic content agreement

QureBio Ltd. Completes Nearly CNY 100 Million Series C1 Financing Led by Efung Capital, accelerating clinical progress in global competition for core ...

SHANGHAI, June 5, 2025 /PRNewswire/ -- Qure Biotechnology (Shanghai) Co., Ltd. (QureBio) announced that it has completed a Series C1 financing round. ...

QureBio Ltd. Completes Nearly CNY 100 Million Series C1 Financing Led by Efung Capital, accelerating clinical progress in global competition for core pipelines

Scinai Immunotherapeutics Receives Italian Government Clearance Under Golden Power Regulation for Potential Acquisition of Pincell S.r.l.

The regulatory approval marks a key milestone toward the potential acquisition of Pincell, removing a major condition precedent under the option agree...

Scinai Immunotherapeutics Receives Italian Government Clearance Under Golden Power Regulation for Potential Acquisition of Pincell S.r.l.

Centinel Spine® Continues to Innovate in Lumbar Total Disc Replacement through the Release of New prodisc® L Instrumentation

Centinel Spine advances its commitment to lumbar total disc replacement (LTDR) with new prodisc L instruments designed to meet evolving customer needs...

Centinel Spine® Continues to Innovate in Lumbar Total Disc Replacement through the Release of New prodisc® L Instrumentation

Penumbra Introduces the Ruby® XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization

ALAMEDA, Calif., June 5, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) announced the U.S. Food and Drug Administration (FDA) clearance and launch of...

Penumbra Introduces the Ruby® XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization

"Morning Complete Ingredients Gave Me My Life Back" - ActivatedYou Morning Complete Hits Over 4,000 Positive Reviews

Morning Complete Reviews Show Customers Nationwide Experiencing Improved Digestive Health, Sustained Energy, and Overall Vitality LOS ANGELES, June 5,...

"Morning Complete Ingredients Gave Me My Life Back" - ActivatedYou Morning Complete Hits Over 4,000 Positive Reviews

Hoth Therapeutics to Spotlight HT-001 in Investor-Focused KOL Event Addressing Breakthrough Combating Cancer Treatment Skin Toxicities

Company Expands IP Portfolio While Advancing Clinical Innovation in Oncology Supportive Care Case Study and Interim Clinical Trial Results Will Be Dis...

Hoth Therapeutics to Spotlight HT-001 in Investor-Focused KOL Event Addressing Breakthrough Combating Cancer Treatment Skin Toxicities

Harvard Research: Radical Remission Workshop Offers Hope to Cancer Patients Amidst Research Cuts

IRVINGTON, N.Y., June 5, 2025 /PRNewswire/ -- Amidst alarming cuts in cancer research funding, there is new urgency for individuals to take control of...

Harvard Research: Radical Remission Workshop Offers Hope to Cancer Patients Amidst Research Cuts

FutureCeuticals, Inc. destaca los beneficios de vitAlign® para la salud celular

- FutureCeuticals, Inc. anuncia una publicación revisada por pares que destaca los beneficios de vitAlign® para la salud celular y el apoyo inmunitari...

FutureCeuticals, Inc. destaca los beneficios de vitAlign® para la salud celular

Immorta Bio's Anti-Aging Stem Cell Product Shows Superiority in Rheumatoid Arthritis in Preclinical Studies

Peer-Reviewed Paper Suggests Stem Cells May Correct Immune Abnormalities Associated with Aging and Autoimmunity MIAMI, June 5, 2025 /PRNewswire/ -- Im...

Immorta Bio's Anti-Aging Stem Cell Product Shows Superiority in Rheumatoid Arthritis in Preclinical Studies

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine

Ketamine faces a current US drug shortage not expected to abate in the near future1 Current ketamine market estimated at $750 million and projected to...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine

New Physician from Leading Sarasota Cardiology Practice to Now Offer the Hybrid Choice™ Concierge Program from Concierge Choice Physicians

Patients can choose a more personalized approach to managing their cardiology care ROCKVILLE CENTRE, N.Y., June 5, 2025 /PRNewswire/ -- Concierge Choi...

New Physician from Leading Sarasota Cardiology Practice to Now Offer the Hybrid Choice™ Concierge Program from Concierge Choice Physicians

Kazia Therapeutics Announces First Patient Dosed in Phase 1b Trial of Paxalisib in Advanced Breast Cancer

Trial is expected to provide key insights on how paxalisib therapy can be combined with established immunotherapies and standard of care chemotherapy ...

Kazia Therapeutics Announces First Patient Dosed in Phase 1b Trial of Paxalisib in Advanced Breast Cancer

Apnimed Announces Multiple Presentations at the Associated Professional Sleep Societies (SLEEP 2025) Annual Meeting Highlighting the Disease Burden an...

CAMBRIDGE, Mass., June 5, 2025 /PRNewswire/ -- Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral ...

Apnimed Announces Multiple Presentations at the Associated Professional Sleep Societies (SLEEP 2025) Annual Meeting Highlighting the Disease Burden and Current Unmet Medical Needs in Obstructive Sleep Apnea (OSA)

Stand Up To Cancer and SandboxAQ Launch Collaboration to Advance Treatment Innovation

The initiative will use SandboxAQ's LQM technology to accelerate new approaches that help treat cancer earlier, when it is most treatable LOS ANGELES,...

Stand Up To Cancer and SandboxAQ Launch Collaboration to Advance Treatment Innovation

"Nutra Complete Dog Food Made My 10-Year-Old Dog a Puppy Again!" - Ultimate Pet Nutrition Nutra Complete Surpasses 1,100 Positive Reviews

Pet Parents Are Raving About Nutra Complete Dog Food, The Veterinarian-Developed Formula That Supports Digestion, Skin, Immunity, and Vitality LOS ANG...

"Nutra Complete Dog Food Made My 10-Year-Old Dog a Puppy Again!" - Ultimate Pet Nutrition Nutra Complete Surpasses 1,100 Positive Reviews